Mass. schools take steps to protect students during solar eclipse
Excitement is building ahead of Monday's eclipse, the first in the U.S. since 2017 — but there is a risk of permanent vision loss without the right equipment.
Stay updated with breaking news from Jason Comander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Excitement is building ahead of Monday's eclipse, the first in the U.S. since 2017 — but there is a risk of permanent vision loss without the right equipment.
Ongoing research offers hope for those at risk of vision loss from this severe IRD
The unprecedented study involves using the gene-editing technique CRISPR to edit a gene while it's still inside a patient's body. In exclusive interviews, NPR talks with two of the first participants.
Josh Andersen/Oregon Health & Science University hide caption toggle caption Josh Andersen/Oregon Health & Science University Carlene Knight, 54, is one of the first patients in a landmark study designed to try to restore vision in those who have a rare genetic disease that causes blindness. Josh Andersen/Oregon Health & Science University Carlene Knight would love to do things that most people take for granted, such as read books, drive a car, ride a bike, gaze at animals in a zoo and watch movies. She also longs to see expressions on people's faces...